Covered recipient · General Payments record
KIM L BANGO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$1,400.60
- Reported across 63 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.25 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $140.04 | 7 |
| Acerta Pharma LLC | $128.85 | 1 |
| Exact Sciences Corporation | $60.86 | 3 |
| Lilly USA, LLC | $57.36 | 3 |
| EISAI INC. | $32.53 | 1 |
| PFIZER INC. | $25.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $128.85 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206280826 | CMS |
| Eisai Inc. | $32.53 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244491972 | CMS |
| Exact Sciences Corporation | $20.43 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235260540 | CMS |
| Exact Sciences Corporation | $17.93 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235260542 | CMS |
| Exact Sciences Corporation | $22.50 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235260544 | CMS |
| Lilly USA, LLC | $18.55 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186685529 | CMS |
| Lilly USA, LLC | $18.78 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186710983 | CMS |
| Lilly USA, LLC | $20.03 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186734035 | CMS |
| Novo Nordisk Inc | $17.90 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188284746 | CMS |
| Novo Nordisk Inc | $22.19 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188161963 | CMS |
| Novo Nordisk Inc | $5.92 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188134337 | CMS |
| Novo Nordisk Inc | $18.76 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188472126 | CMS |
| Novo Nordisk Inc | $19.68 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188298805 | CMS |
| Novo Nordisk Inc | $26.92 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188160872 | CMS |
| Novo Nordisk Inc | $28.67 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188163479 | CMS |
| PFIZER INC. | $25.61 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229607678 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.